Effect of Radiofrequency on Insulin Resistence in Obese Post Menopansal Women
NCT ID: NCT05818293
Last Updated: 2023-07-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
52 participants
INTERVENTIONAL
2023-07-09
2023-11-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
So, RF technology deployed by Vanquish uses oscillating electrical current forcing collisions between charged molecules and ions, which are then transformed into heat. Since fat biophysical characteristics behave like an insulator capable of polarization, it absorbs the high RF-related heat release from the RF applicator driving specific fat necrosis and consequent lipolysis. Patients lay underneath the device while the focused-field radiofrequency heats up the underlying .
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Cryolipolysis on Insulin Resistance
NCT06223490
Effect of Laser Acupuncture on Metabolic Syndrome in Obese Postmenopausal Women
NCT05651451
Health Effects of Liposuction in Overweight Women With Elevated Insulin Levels, Impaired Glucose Tolerance and/or Type 2 Diabetes
NCT00005760
Study of Fat Tissue's Ability to Take up Sugar in the Obese Population
NCT02994459
Effectiveness of Low Level Laser Therapy on Insulin Resistance and Inflammatory Biomarkers
NCT04477109
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Each group will be twenty six women. Group (A) (study group) will receive radiofrequency, medical standard care for insulin resistance and regular diet habits. This group will receive 30 minutes on the abdominal area by radiofrequency, twice per week. The treatment procedure consists of placing the emitting panel over abdomen and flanks close to the skin using a spacer which standardizes distance between the panel and the body surface.
Once it is in supine position, with a pillow under their heads and with their knees in flexion. Initially, the abdominal region of each participant was divided into two equal parts- right and left-with the line Alba as reference.
Group (B) (control group) will receive regular diet habits only.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
* Twenty six post-menopausal women in group (A) will receive RF, is a healthy and effective method for reducing the abdominal obesity regulation of insulin secretion, and enhance quality of life of post-menopausal women. It will be directed to group (A) only .
* Group (A) will receive 30 minutes on the abdominal area, twice per week, as recommended in the standard treatment protocol by the manufacturer. Group (B) (control group) will receive regular diet habits only.
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
study group -control group
Group (A) (study group) will receive radiofrequency, medical standard care for insulin resistance and regular diet habits.
radiofrquency device
• The radiofrequency system has been used for treatment of subcutaneous fat layers.
control group
Group (B) (control group) will receive regular diet habits only.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
radiofrquency device
• The radiofrequency system has been used for treatment of subcutaneous fat layers.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* All participants' ages will be ranged from 48-60 years old.
* All participants BMI will exceed 30 kg/m2.
* All participants waist hip ratio will be equal or more than 0, 89.
Exclusion Criteria
* Untreated hypo- or hyperthyroidism.
* Uncontrolled liver, kidney or cardiovascular disease or diabetes.
* Implanted pacemaker or metal implant.
* History of thrombophlebitis, any hematological disease.
* No past or present neurological and musculoskeletal disorders that will have affected health condition.
* No smoking and drinking habits.
* No psychological problems.
48 Years
60 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shymaa Mohammed Abdo Mohammed
physiotherapist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shymaa M. Mohammed, MSC
Role: PRINCIPAL_INVESTIGATOR
Cairo University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hadiek El Maadi center
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
012/003806
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.